zacitidine (AZA) Prolongs Overall Survival in Older Patients with Acute Myeloid Leukemia (AML) with Poor Prognostic Karyotypes Compared with Conventional Care Regimens (CCR)
Doehner H., Vyas P., Seymour JF., Santini V., Stone RM., Minden MD., Al-Ali HK., Del Castillo TB., Morrill J., Songer S., Weaver J., Skikne BS., Beach CL., Dombret H.